Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C Virus Infection

Explore clinical trials studying Hepatitis C Virus Infection. Study availability and eligibility vary by location and protocol.

79 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C Virus Infection trial results

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection

NCT02249182

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • San Francisco, California, United States
  • Aurora, Colorado, United States
View all 31 locations
View Trial Details
Completed

Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection

NCT02175758

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Los Angeles, California, United States
  • San Francisco, California, United States
  • Washington D.C., District of Columbia, United States
  • Gainesville, Florida, United States
View all 37 locations
View Trial Details
Completed

Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

NCT03118843

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Stanford Hospital and Clinics Palo Alto, California, United States
  • Inland Empire Liver Foundation Rialto, California, United States
View all 27 locations
View Trial Details
Completed

Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

NCT03074331

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Seth GS Medical College and KEM hospital Mumbai, Maharashtra, India
  • Government Medical College & Super Speciality Hospital Nagpur, Maharashtra, India
  • Institute of Liver and Biliary Sciences New Delhi, National Capital Territory of Delhi, India
  • All India Institute of Medical Sciences Delhi, New Delhi, India
View all 16 locations
View Trial Details
Completed

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

NCT02639247

Conditions
Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +20 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Pasadena, California, United States
View all 78 locations
View Trial Details
Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV

NCT02671500

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Beijing Ditan Hospital Chaoyang, Beijing Municipality, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • The Third Affiliated Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
View all 38 locations
View Trial Details

Related conditions